This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignee: Recursion Pharmaceuticals, Inc.. Active years: 2024-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024-2026
Title: Michael James Genin: Innovator in Heterocyclic Compounds
Introduction
Michael James Genin is a notable inventor based in Draper, UT (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of heterocyclic compounds. With a total of 2 patents to his name, Genin's work is recognized for its potential impact on treating various diseases and disorders.
Latest Patents
Genin's latest patents focus on heterocyclic compounds and related methods. The patents detail compounds of Formula (I) and Formula (II), including their stereoisomers, tautomers, and pharmaceutically acceptable salts or solvates. These patents also describe pharmaceutical compositions that incorporate these compounds and outline methods for treating diseases, disorders, or conditions using these innovative formulations.
Career Highlights
Michael James Genin is currently associated with Recursion Pharmaceuticals, Inc., where he continues to advance his research in pharmaceutical innovations. His work at Recursion Pharmaceuticals emphasizes the importance of developing new therapeutic options through innovative chemical compounds.
Collaborations
Throughout his career, Genin has collaborated with notable colleagues, including Carl Brooks and Joseph Walter Carpenter. These collaborations have contributed to the advancement of research and development in the pharmaceutical sector.
Conclusion
Michael James Genin is a distinguished inventor whose work in heterocyclic compounds holds promise for the future of medicine. His contributions to the field are significant, and his ongoing research continues to pave the way for innovative treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile